The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.60
Bid: 27.60
Ask: 27.90
Change: 0.00 (0.00%)
Spread: 0.30 (1.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 27.60
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

31 Mar 2015 10:00

RNS Number : 9778I
Marston's PLC
31 March 2015
 

 

31 March 2015

 

MARSTON'S PLC

ACQUISITION

 

Marston's PLC ("Marston's") is pleased to announce that it has reached agreement with Daniel Thwaites plc ("Thwaites") to acquire the trading operations of Thwaites' beer division. The acquisition includes two leading, premium brands: Wainwright and Lancaster Bomber ales. The total cash consideration is £25.1 million excluding working capital.

 

Marston's has been brewing Thwaites' beers since early 2014. As part of this acquisition, we have entered into a long-term exclusive agreement to supply all beer, wine, spirits and minerals to Thwaites' pub estate.

 

Thwaites' beer division is a high quality sales business of scale concentrated in the North West of England, including a 150-strong team of regional sales, marketing and distribution staff operating in the Independent Free Trade, National On Trade and National Off Trade channels. The business has shown good growth in recent years, including the acquisition of Hydes Brewery's free trade business in 2012 which increased Thwaites' business in Manchester.

 

Thwaites' two principal beer brands are Wainwright, one of the most popular golden cask ales in the UK and Lancaster Bomber, a premium ale. Both brands have won numerous awards in recent years and are highly complementary to Marston's market-leading portfolio of premium craft and bottled ales.

 

This acquisition is consistent with Marston's brewing strategy to focus on popular premium ales with local and regional appeal, and provides an opportunity to capitalise on the developing free trade market and wider consumer interest in the beer category.

 

The transaction is expected to complete on 17 April 2015. In the 12 months to December 2014 EBITDA is estimated to have been around £7 million before overheads of approximately £2 million. The acquisition is expected to be earnings-enhancing in the first full year of ownership; in the current financial year it is estimated that the contribution to profit before taxation will be around £1.5 million.

 

Commenting on the transaction, Ralph Findlay, Chief Executive Officer of Marston's, said:

 

"I am delighted to welcome our new colleagues to Marston's. We are acquiring a very high quality business with good people and brands, and with growth potential. The acquisition is consistent with our beer business strategy to focus on local provenance and premium brands, and provides opportunity to capitalise on the developing free trade market and increasing consumer interest in the beer category."

 

 

Enquires:

 

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2020

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial Officer

Matthew Smallwood

 

NOTES TO EDITORS

â—‹

Marston's is a leading pub operator and independent brewer.

â—‹

It has an estate of around 1,700 pubs situated nationally, comprising managed, franchised and leased pubs.

â—‹

It is the UK's leading brewer of premium cask and bottled ales, including Marston's Pedigree and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers.

â—‹

Marston's employs around 13,000 people.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLIFSTVDILVIE
Date   Source Headline
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.